Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T21:52:00.357Z.
Calculation as of: 2026-10-06T21:52:00.357Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e4c5e5530b5f4ff9b2ae64c4564a307684e7c74323ce66c5db527ab157f5d0a0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
IceCure Medical Ltd
Market Cap
$2.86M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| IceCure Medical Ltd (ICCM) | $2.86M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $2.94M | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.69M | N/A |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.66M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.25M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
